作者单位:
University of Ljubljana, Faculty of Pharmacy, The Chair of Pharmaceutical Chemistry, Aškerčeva 7, SI-1000 Ljubljana, Slovenia; Global Drug Development, Technical Research & Development, Novartis, Biologics Technical Development Mengeš, Drug Product Development Biosimilars, Lek Pharmaceuticals d.d., Kolodvorska 27, SI-1234 Mengeš, Slovenia.
[1]
University of Ljubljana, Faculty of Pharmacy, The Chair of Pharmaceutical Chemistry, Aškerčeva 7, SI-1000 Ljubljana, Slovenia.
[2]
Global Drug Development, Technical Research & Development, Novartis, Biologics Technical Development Mengeš, Drug Product Development Biosimilars, Lek Pharmaceuticals d.d., Kolodvorska 27, SI-1234 Mengeš, Slovenia. Electronic address: roman.sink@novartis.com.
[3]
University of Ljubljana, Faculty of Pharmacy, The Chair of Pharmaceutical Chemistry, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. Electronic address: stane.pajk@ffa.uni-lj.si.
[4]
DOI
10.1016/j.ejpb.2020.07.010
PMID
32693155
发布时间
2021-06-02